amy: peter maybarduk, if you can respond to what some of the republicans have said?i mean, across the political spectrum, this seems to be appreciated, to say the least, but the question is, like sanders has raised, senator sanders, why it is so limited? ahead of the midterm elections, congressman kevin brady said repealing the law could be a republican agenda item because those drug provisions are so dangerous by discouraging investment in lifesaving cures. is this discouraging investment in lifesaving cures or or is it just going to stock buybacks? >> much of it is going to buybacks. it is not discouraging investment. those critics are out of step with public opinion. recent polls show 83% of americans favor some warm up drug price negotiation. -- some form of drug price negotiation. the american people support development to the tune of $42 billion a year to the national institutes of health. almost every single new drug that comes to market has benefited from taxpayer subsidies of the research and develop agenda. in addition to the many tax breaks. further, price